JRCT ID: jRCTs041180053
Registered date:26/02/2019
JROSG 10-2
Basic Information
| Recruitment status | Complete |
|---|---|
| Health condition(s) or Problem(s) studied | squamous cell carcinoma of the anal canal |
| Date of first enrollment | 27/01/2014 |
| Target sample size | 40 |
| Countries of recruitment | |
| Study type | Interventional |
| Intervention(s) | Concurrent chemoradiation(5FU/MMC) |
Outcome(s)
| Primary Outcome | 2years disease free survival |
|---|---|
| Secondary Outcome | Over all survival, Local control rate, colostomy free survival, toxicity |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | <= 80age old |
| Gender | Both |
| Include criteria | anal canal cancer patients, cT1-4N0-3M0 |
| Exclude criteria | Previously irradiated for pelvis, malignant tumor history |
Related Information
| Primary Sponsor | Murofushi Keiko |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) | UMIN000012184 |
Contact
| Public contact | |
| Name | Keiko Murofushi |
| Address | 3-18-22 Honkomagome, Bunkyo-ku,Tokyo Tokyo Japan 113-0021 |
| Telephone | +81-3-3823-2101 |
| kmurofushi0918@gmail.com | |
| Affiliation | Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital |
| Scientific contact | |
| Name | Keiko Murofushi |
| Address | 3-18-22 Honkomagome, Bunkyo-ku,Tokyo Tokyo Japan 113-0021 |
| Telephone | +81-3-3823-2101 |
| kmurofushi0918@gmail.com | |
| Affiliation | Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital |